383 related articles for article (PubMed ID: 28461246)
21. Interaction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis.
Liu C; Wu Y; Ma J
Cancer Lett; 2020 Nov; 493():207-216. PubMed ID: 32822816
[TBL] [Abstract][Full Text] [Related]
22. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
[TBL] [Abstract][Full Text] [Related]
23. The Emerging Link between the Hippo Pathway and Non-coding RNA.
Shimoda M; Moroishi T
Biol Pharm Bull; 2020; 43(1):1-10. PubMed ID: 31902912
[TBL] [Abstract][Full Text] [Related]
24. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
[TBL] [Abstract][Full Text] [Related]
25. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
26. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.
Pogribny IP; Rusyn I
Cancer Lett; 2014 Jan; 342(2):223-30. PubMed ID: 22306342
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
Charrez B; Qiao L; Hebbard L
World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
[TBL] [Abstract][Full Text] [Related]
30. [Research advances in diagnostic and therapeutic application of long-chain non-coding RNAs in hepatocellular carcinoma].
Li WX; Li Q; Lin Y; Huang YX; Chen L
Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):628-631. PubMed ID: 27788714
[TBL] [Abstract][Full Text] [Related]
31. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J
Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168
[TBL] [Abstract][Full Text] [Related]
32. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma.
Law PT; Wong N
J Gastroenterol Hepatol; 2011 Mar; 26(3):437-49. PubMed ID: 21332540
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.
Zhang B; Han S; Feng B; Chu X; Chen L; Wang R
Exp Mol Med; 2017 Feb; 49(2):e293. PubMed ID: 28186085
[TBL] [Abstract][Full Text] [Related]
34. MTA2 promotes HCC progression through repressing FRMD6, a key upstream component of hippo signaling pathway.
Guan C; Chang Z; Gu X; Liu R
Biochem Biophys Res Commun; 2019 Jul; 515(1):112-118. PubMed ID: 31128910
[TBL] [Abstract][Full Text] [Related]
35. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.
Wang H; Lu Z; Zhao X
J Hematol Oncol; 2019 Dec; 12(1):133. PubMed ID: 31815633
[TBL] [Abstract][Full Text] [Related]
36. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway.
Ji J; Tang J; Deng L; Xie Y; Jiang R; Li G; Sun B
Oncotarget; 2015 Dec; 6(40):42813-24. PubMed ID: 26540343
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
38. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma.
Yuan SX; Zhang J; Xu QG; Yang Y; Zhou WP
Cancer Lett; 2016 Sep; 379(2):239-44. PubMed ID: 26282784
[TBL] [Abstract][Full Text] [Related]
40. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma.
Yang X; Xie X; Xiao YF; Xie R; Hu CJ; Tang B; Li BS; Yang SM
Cancer Lett; 2015 May; 360(2):119-24. PubMed ID: 25721084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]